Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear Cells
Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is ...
Revelation Biosciences: Gemini priming attenuates inflammatory response in PBMCs
Revelation Biosciences (REVB) announced Gemini priming attenuates the inflammatory response in human peripheral blood mononuclear cells exposed ...
REVB Announces Positive Test Results
REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) is a life sciences company focused on the development of immunologic-based therapies for the prevention and treatment of ...
Zacks Small Cap Research on MSN15h
INAB: Introducing INB-600, A γδ T Cell Engager Platform
INAB READ THE FULL INAB RESEARCH REPORT Following the announcement of its new γδ T cell engager platform INB-600, IN8bio, Inc ...